Learn how cost recovery applies to Australia's Medicinal Cannabis Scheme, including regulatory fees, financial reporting and forecasts for 2024–25 and beyond.
The Cost Recovery Implementation Statement (CRIS) explains how the Department of Health, Disability and Ageing implements cost recovery for regulatory activities associated with the Medicinal Cannabis Scheme.
The statement provides transparency about the costs of administering the scheme and how those costs are recovered from regulated entities.
Cost recovery involves government agencies charging individuals or organisations for some or all of the efficient costs of delivering regulatory activities. This may include application fees, annual charges and other regulatory fees.
The Medicinal Cannabis Scheme operates under the Narcotic Drugs Act 1967 and includes licensing, permit administration, compliance and other regulatory activities.
The CRIS includes:
The statement contains financial forecasts for:
